Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...

Health services company Humana announced its first Humana Cognitive Games. 1 The event is designed to give older adults both ...

Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...

The SVP of educational development’s contribution to the book displays SKNV’s approach to furthering education and ...

Priority review was based on results from the Phase IIb SunRISe-1 trial, which showed that patients treated with TAR-200 for ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

Research from a recent Cadent study reveals the growing impact of TV and connected TV advertising in raising medication ...

Boehringer Ingelheim, one of the industry leading investors in research and development in innovative life expectancy ...

Executives who treat capital allocation as a CEO-level strategic discipline are best positioned to thrive in a volatile and ...

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, explains how E7386 and lenvatinib work together to ...

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

The reality TV star and certified obesity physician Dr. Holly Lofton plan to use the show to further educate GLP-1 users on ...